Animal models of anorexia and cachexia

被引:62
作者
DeBoer, Mark D. [1 ]
机构
[1] Univ Virginia, Div Pediat Endocrinol, Charlottesville, VA 22908 USA
关键词
animal models; cachexia; cancer; chronic heart failure; chronic kidney disease; ghrelin; melanocortin; LEAN BODY-MASS; TUMOR-BEARING MICE; MELANOCORTIN-4 RECEPTOR ANTAGONIST; AGOUTI-RELATED PEPTIDE; CANCER ANOREXIA; FOOD-INTAKE; GHRELIN TREATMENT; THERAPY INSIGHT; NECROSIS-FACTOR; HEART-FAILURE;
D O I
10.1517/17460440903300842
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Background: Cachexia is a devastating syndrome of body wasting that worsens quality of life and survival for patients suffering from diseases such as cancer, chronic kidney disease and chronic heart failure. Successful treatments have been elusive in humans, leaving a clear need for the development of new treatment compounds. Animal models of cachexia are able to recapitulate the clinical findings from human disease and have provided a much-needed means of testing the efficacy of prospective therapies. Objective: This review focuses on animal models of cachexia caused by cancer, chronic heart failure and chronic kidney disease, including the features of these models, their implementation and commonly followed outcome measures. Conclusion: Given the dire clinical need for effective treatments of cachexia, animal models will continue to play a vital role in assessing the efficacy and safety of potential treatments prior to testing in humans. Also important in the future will be the use of animal models to assess the durability of effects from anti-cachexia treatments and their effect on prognosis of the underlying disease states.
引用
收藏
页码:1145 / 1155
页数:11
相关论文
共 85 条
[1]
AKASHI YJ, 2008, INT J CARDIOL
[2]
The syndrome of cardiac cachexia [J].
Anker, SD ;
Sharma, R .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 85 (01) :51-66
[3]
Wasting as independent risk factor for mortality in chronic heart failure [J].
Anker, SD ;
Ponikowski, P ;
Varney, S ;
Chua, TP ;
Clark, AL ;
WebbPeploe, KM ;
Harrington, D ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
LANCET, 1997, 349 (9058) :1050-1053
[4]
Mediators involved in the cancer anorexia-cachexia syndrome:: past, present, and future [J].
Argilés, JM ;
Busquets, S ;
García-Martínez, C ;
López-Soriano, FJ .
NUTRITION, 2005, 21 (09) :977-985
[5]
BARAZZONI R, 2009, KIDNEY INT IN PRESS
[6]
Batra AK, 2008, J INVEST MED, V56, P229
[7]
BECK SA, 1987, CANCER RES, V47, P5919
[8]
BIBBY MC, 1987, JNCI-J NATL CANCER I, V78, P539
[9]
Blockade of central melanocortin signaling promotes accumulation of lean body mass in rodent models of chronic heart failure. [J].
Bowe, D. D. ;
Scarlett, J. M. ;
Basra, A. K. ;
Steiner, R. A. ;
Marks, D. L. .
JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) :S77-S77
[10]
Anticachectic effects of formoterol:: A drug for potential treatment of muscle wasting [J].
Busquets, S ;
Figueras, MT ;
Fuster, G ;
Almendro, V ;
Moore-Carrasco, R ;
Ametller, E ;
Argilés, JM ;
López-Soriano, FJ .
CANCER RESEARCH, 2004, 64 (18) :6725-6731